Preformulation Studies of Varenicline for Formulation and Development of a Novel Orally Disintegrating Film

Prakruti Amin *

Gujarat Technological University, Ahmedabad, Gujarat, India and Department of Pharmaceutics, Kadi Sarva Vishwavidyalaya, K. B. Institute of Pharmaceutical Education and Research, Gandhinagar, Gujarat, India.

Manish Patel

Department of Pharmaceutics, L. M. College of Pharmacy, Gujarat Technological University, Ahmedabad, Gujarat, India.

*Author to whom correspondence should be addressed.


Abstract

Objective: The major goal of pre-formulation research is to create a drug delivery system that is stable, elegant, safe, and effective by determining the drug's kinetic profile, the formulation's compatibility with various excipients, and the physico-chemical characteristics of new drug molecules. This could offer crucial support for executing formulation design or the need for the molecular change. Therefore, in the current study, studies on Varenicline (VAR)'s appropriateness for oral formulation were conducted. Similar to cytisine, VAR functions as a partial nicotine receptor agonist. It blocks alpha-4-beta-2 nicotinic acetylcholine receptor subtypes and is a partial agonist. Through partial agonism, VAR reduces the urge and withdrawal symptoms associated with quitting efforts by inhibiting the dopaminergic activation brought on by smoking. It stops nicotine from stimulating the mesolimbic dopamine pathway, which is linked to nicotine addiction.

Methods: The authenticity of VAR was established by DSC and FTIR spectra. A UV spectrophotometric method was employed for determination of VAR in bulk and active pharmaceutical ingredient (API).

Results: The authenticity of VAR was established by DSC and FTIR spectra. For the determination of VAR in bulk API (active pharmaceutical ingredient), a UV spectrophotometric approach was used. In the concentration range of 5–40 g/ml, the UV technique was linear. The lower% CV values of intraday and interday variability indicate the proposed methodology's robustness. The higher regression coefficient value(0.999) indicates the methodology is robust.

Conclusions: The outcome of the physico-chemical experiments of drug molecule indicates suitability of oral route. Additionally, at different conditions like solid as well as liquid state, the drugmoleculewasobservedstable.

Keywords: Preformulation, varenicline, oralformulation, orallydisintegrating film, stability


How to Cite

Amin , P. and Patel , M. (2023) “Preformulation Studies of Varenicline for Formulation and Development of a Novel Orally Disintegrating Film”, Journal of Pharmaceutical Research International, 35(17), pp. 31–40. doi: 10.9734/jpri/2023/v35i177388.

Downloads

Download data is not yet available.

References

Filipa BA, Claudia S, Jorge FJ, Sergio Coelho S. Oral films: Current status and future perspectives II — Intellectual property, technologies and market needs, J. Control. Release. 2015;206:108–121.

Mariagiovanna S, Sven S, WenKai H, Heinz P, Simon G, Massimo B, Amrit P, Mine O. Orodispersible films: Towards drug delivery in special populations, Int. J. Pharm. 2017;523:327–335.

Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 1992;81:1–10.

Shojaei AH, Chang RK, Guo X. Systemic drug delivery via the buccal mucosal route.J. Pharm. Technol. 2001;25(6): 70–81.

Galey WR, Lonsdale HK, Nacht S. The In vitro permeability of skin and buccal mucosa toselected drugs and tritiated water, J. Invest. Dermat.

Lam JKW, et al. Oral transmucosal drug delivery for pediatric use, Adv. Drug Deliv. Rev; 2013.

Available:http://dx.doi.org/10.1016/j.addr. 2013.08.011

Squier CA. The permeability of oral mucosa, Crit. Rev. Oral Biol. Med. 1991; 2:13–32.

SatheeshMadhav NV, Semwal R, Semwal DK, Semwal RB. Recent trends in oral transmucosal drug delivery systems: an emphasis on the soft palatal route, Expert Opin. Drug Deliv. 2012;9:629–647.

Branca MA. Silvaa,b, Ana Filipa Borgesa, b Cláudia Silvaa, Jorge FJ. Coelhoc Sérgio Simõesa. International Journal of Pharmaceutics. 2015;494(1):537-551.

Alok Khunteta, Manish Kumar Gupta, Surendra Kumar Swarnkar. Preformulation studies of rapid dissolving films containing granisetron hydrochloride. Journal of Drug Delivery & Therapeutics. 2019;9(4-A): 511-515

Liang AC, Chen LH. Fast dissolving intraoral drug delivery systems. Exp. Opin. Ther. Patents. 2001;11(6):981–986.

Borsadia S, O'Halloran D, Osborne JL. Quick dissolving films-a novel approach to drug delivery. Drug Delivery Technology. 2003;3(3).

Prabhu SC, Parsekar SD, Shetty A, et al. Review article a review on fast dissolving sublingual films for systemic drug delivery. Int J Pharm ChemSci. 2014;3:501–511.

Russo E, Selmin F, Baldassari S, et al. A focus on mucoadhesive polymers and their application in buccal dosage forms. J Drug DelivSciTechnol. 2015;32:113–125

Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int J Pharm. 2011;404:1–9.

Cides LCS. et al. Thermal behaviour, compatibility study and decomposition kinetics of Varenicline under isothermaland non-isothermal conditions. Journal of Thermal Analysis and Calorimetry; 2006.